These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37267179)

  • 1. Investigating Secondary Alcohol Outcomes in a Contingency Management Intervention among American Indian and Alaska Native Adults.
    Hirchak KA; Kordas G; Lyons AJ; Herron J; Jansen K; Shaw J; McPherson SM; Roll J; Buchwald D; McDonell MG;
    J Addict Med; 2023 May-Jun 01; 17(3):e177-e182. PubMed ID: 37267179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Incentives for Alcohol Abstinence in Partnership With 3 American Indian and Alaska Native Communities: A Randomized Clinical Trial.
    McDonell MG; Hirchak KA; Herron J; Lyons AJ; Alcover KC; Shaw J; Kordas G; Dirks LG; Jansen K; Avey J; Lillie K; Donovan D; McPherson SM; Dillard D; Ries R; Roll J; Buchwald D;
    JAMA Psychiatry; 2021 Jun; 78(6):599-606. PubMed ID: 33656561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contingency management for alcohol use disorder reduces cannabis use among American Indian and Alaska Native adults.
    Hirchak KA; Lyons AJ; Herron JL; Kordas G; Shaw JL; Jansen K; Avey JP; McPherson SM; Donovan D; Roll J; Buchwald D; Ries R; McDonell MG;
    J Subst Abuse Treat; 2022 Jun; 137():108693. PubMed ID: 34952747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cultural Factors and Alcohol Use in American Indian Adults: Results From a Culturally Tailored Contingency Management Intervention.
    Herron J; Hirchak KA; Venner K; Tofighi D; McDonell MG;
    J Stud Alcohol Drugs; 2023 Mar; 84(2):273-280. PubMed ID: 36971715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment ethyl glucuronide levels predict response to a contingency management intervention for alcohol use disorders among adults with serious mental illness.
    McDonell MG; Leickly E; McPherson S; Skalisky J; Hirchak K; Oluwoye O; Srebnik D; Roll JM; Ries RK
    Am J Addict; 2017 Oct; 26(7):673-675. PubMed ID: 28833832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the Predictive Validity of the Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES) in Alaska Native and American Indian People.
    Lillie KM; Jansen KJ; Dirks LG; Lyons AJ; Alcover KC; Avey JP; Hirchak K; Herron J; Buchwald D; Donovan DM; McDonell MG; Shaw JL
    J Addict Med; 2020; 14(5):e241-e246. PubMed ID: 32371661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The rewarding recovery study: a randomized controlled trial of incentives for alcohol and drug abstinence with a rural American Indian community.
    McDonell MG; Skalisky J; Burduli E; Foote A; Granbois A; Smoker K; Hirchak K; Herron J; Ries RK; Echo-Hawk A; Barbosa-Leiker C; Buchwald D; Roll J; McPherson SM
    Addiction; 2021 Jun; 116(6):1569-1579. PubMed ID: 33220122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Randomized Controlled Trial of Ethyl Glucuronide-Based Contingency Management for Outpatients With Co-Occurring Alcohol Use Disorders and Serious Mental Illness.
    McDonell MG; Leickly E; McPherson S; Skalisky J; Srebnik D; Angelo F; Vilardaga R; Nepom JR; Roll JM; Ries RK
    Am J Psychiatry; 2017 Apr; 174(4):370-377. PubMed ID: 28135843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focus groups to increase the cultural acceptability of a contingency management intervention for American Indian and Alaska Native Communities.
    Hirchak KA; Leickly E; Herron J; Shaw J; Skalisky J; Dirks LG; Avey JP; McPherson S; Nepom J; Donovan D; Buchwald D; McDonell MG;
    J Subst Abuse Treat; 2018 Jul; 90():57-63. PubMed ID: 29866384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A culturally-tailored behavioral intervention trial for alcohol use disorders in three American Indian communities: Rationale, design, and methods.
    McDonell MG; Nepom JR; Leickly E; Suchy-Dicey A; Hirchak K; Echo-Hawk A; Schwartz SM; Calhoun D; Donovan D; Roll J; Ries R; Buchwald D
    Contemp Clin Trials; 2016 Mar; 47():93-100. PubMed ID: 26706667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-reaction of propyl and butyl alcohol glucuronides with an ethyl glucuronide enzyme immunoassay.
    Arndt T; Beyreiß R; Schröfel S; Stemmerich K
    Forensic Sci Int; 2014 Aug; 241():84-6. PubMed ID: 24887323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Filling the gap between lab and clinical impact: An open randomized diagnostic trial comparing urinary ethylglucuronide and ethanol in alcohol dependent outpatients.
    Barrio P; Teixidor L; Ortega L; Lligoña A; Rico N; Bedini JL; Vieta E; Gual A
    Drug Alcohol Depend; 2018 Feb; 183():225-230. PubMed ID: 29291550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contingency management intervention targeting co-addiction of alcohol and drugs among American Indian adults: Design, methodology, and baseline data.
    Burduli E; Skalisky J; Hirchak K; Orr MF; Foote A; Granbois A; Ries R; Roll JM; Buchwald D; McDonell MG; McPherson SM
    Clin Trials; 2018 Dec; 15(6):587-599. PubMed ID: 30156433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot investigation of a phosphatidylethanol-based contingency management intervention targeting alcohol use.
    McDonell MG; Skalisky J; Leickly E; Orr MF; McPherson S; Roll J; Hill-Kapturczak N; Javors M
    Psychol Addict Behav; 2017 Aug; 31(5):608-613. PubMed ID: 28714726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Performance of Alcohol Markers Including Ethyl Glucuronide and Ethyl Sulphate to Detect Alcohol Use in Clients in a Community Alcohol Treatment Programme.
    Armer JM; Gunawardana L; Allcock RL
    Alcohol Alcohol; 2017 Jan; 52(1):29-34. PubMed ID: 27998921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary investigations on ethyl glucuronide and ethyl sulfate cutoffs for detecting alcohol consumption on the basis of an ingestion experiment and on data from withdrawal treatment.
    Albermann ME; Musshoff F; Doberentz E; Heese P; Banger M; Madea B
    Int J Legal Med; 2012 Sep; 126(5):757-64. PubMed ID: 22752748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urine Ethyl Glucuronide Unraveling the Reality of Abstinence Monitoring in a Routine Outpatient Setting: A Cross-Sectional Comparison with Ethanol, Self Report and Clinical Judgment.
    Barrio P; Teixidor L; Rico N; Bruguera P; Ortega L; Bedini JL; Gual A
    Eur Addict Res; 2016; 22(5):243-8. PubMed ID: 27220985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethyl glucuronide and ethyl sulfate assays in clinical trials, interpretation, and limitations: results of a dose ranging alcohol challenge study and 2 clinical trials.
    Jatlow PI; Agro A; Wu R; Nadim H; Toll BA; Ralevski E; Nogueira C; Shi J; Dziura JD; Petrakis IL; O'Malley SS
    Alcohol Clin Exp Res; 2014 Jul; 38(7):2056-65. PubMed ID: 24773137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between the urinary alcohol markers EtG, EtS, and GTOL/5-HIAA in a controlled drinking experiment.
    Høiseth G; Bernard JP; Stephanson N; Normann PT; Christophersen AS; Mørland J; Helander A
    Alcohol Alcohol; 2008; 43(2):187-91. PubMed ID: 18230699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lessons learned from a case of tert-butyl glucuronide excretion in urine - "New" psychoactive alcohols knocking on the back door?
    Arndt T; Buschmann HC; Schulz K; Stemmerich K
    Forensic Sci Int; 2017 Dec; 281():9-12. PubMed ID: 29101909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.